Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001616445 | SCV001840165 | benign | not provided | 2020-03-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002070483 | SCV002329451 | benign | KBG syndrome | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002070483 | SCV002525154 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002370249 | SCV002667997 | likely benign | Inborn genetic diseases | 2023-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003966250 | SCV004783621 | likely benign | ANKRD11-related disorder | 2021-11-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |